Spebrutinib besylate
CAS: 1360053-81-1
Ref. 3D-KEC05381
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Product Information
Spebrutinib besylate is a salt form of spebrutinib, which is a small molecule tyrosine kinase inhibitor. It has been shown to inhibit the proliferation of lymphocytes in vitro and in vivo. The mechanism by which spebrutinib besylate inhibits cell proliferation is not fully understood, but it may be due to inhibition of tyrosine kinases and their downstream signaling pathways. Spebrutinib besylate also has potential antineoplastic activity, as it targets family members that are involved in the development and progression of lymphoma.
Chemical properties
Technical inquiry about: 3D-KEC05381 Spebrutinib besylate
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
